Connective tissue diseases: Predicting death in SSc: Planning and cooperation are needed

Nature Reviews Rheumatology

Volumn 7, Issue 11, 2011, Pages 628-630

  Domsic, Robyn T ^a   Medsger Jr , Thomas A ^a  

^a Division of Rheumatology and Clinical Immunology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE DURATION; EVIDENCE BASED MEDICINE; HEALTH CARE NEED; HEALTH CARE PLANNING; HUMAN; LUNG FIBROSIS; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RISK ASSESSMENT; SCREENING TEST; SURVIVAL TIME; SYSTEMIC SCLEROSIS; VALIDATION PROCESS;

HUMANS; MODELS, STATISTICAL; PROGNOSIS; SCLERODERMA, SYSTEMIC; SURVIVAL RATE;

EID: 80455176955     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.152     Document Type: Article

References (10)

1. Steen, V. D. & Medsger, T. A. Changes in causes of death in systemic sclerosis, 1972-2002. Ann. Rheum. Dis. 66, 940-944 (2007).
2. Al-Dhaher, F. F., Pope, J. E. & Ouimet, J. M. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin. Arthritis Rheum. 39, 269-277 (2010).
3. Nihtyanova, S. et al. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM 103, 109-115 (2010).
4. Fransen, J. et al. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann. Rheum. Dis. 70, 1788-1792 (2011).
5. Bryan, C., Howard, Y., Brennan, P., Black, C. & Silman, A. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br. J. Rheumatol. 35, 1122-1126 (1996).
6. Wilson, P. W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837-1847 (1998).
7. Wasson, J. H., Sox, H. C., Neff, R. K. & Goldman, L. Clinical prediction rules. Applications and methodological standards. N. Engl. J. Med. 313, 793-799 (1985).
8. Laupacis, A., Sekar, N. & Stiell, I. G. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 277, 488-494 (1997).
9. Toll, D. B., Janssen, K. J., Vergouwe, Y. & Moons, K. G. Validation, updating and impact of clinical prediction rules: a review. J. Clin. Epidemiol. 61, 1085-1094 (2008).
10. Altman, D. G. & Royston, P. What do we mean by validating a prognostic model? Stat. Med. 19, 453-473 (2000).